Loading...

Dr George Au-Yeung gives insights on ovarian cancer signal-seeking study IGNITE

2,200 ANZ women are diagnosed with ovarian cancer every year, and less than half will survive beyond five years. ANZGOG’s IGNITE trial is testing how effective a new treatment is for patients with relapsed high grade [...]

Dr George Au-Yeung gives insights on ovarian cancer signal-seeking study IGNITE2024-02-14T11:19:47+11:00
Go to Top